Cargando…
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
BACKGROUND: So far only single cases with short follow-up have been reported on the use of intravitreal anti-VEGF for traumatic choroidal neovascularizations (CNV). This paper reports a large case series of patients with CNV secondary to choroidal rupture after ocular trauma receiving intravitreal a...
Autores principales: | Barth, T., Zeman, F., Helbig, H., Gamulescu, M.-A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6878647/ https://www.ncbi.nlm.nih.gov/pubmed/31771544 http://dx.doi.org/10.1186/s12886-019-1242-7 |
Ejemplares similares
-
Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to a bilateral choroidal osteoma
por: Zafar, Sidra, et al.
Publicado: (2016) -
Successful management of choroidal neovascular membrane secondary to choroidal osteoma with intravitreal bevacizumab
por: Takkar, Brijesh, et al.
Publicado: (2017) -
Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis
por: Shah, Nikunj J, et al.
Publicado: (2011) -
Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis
por: Pandey, Neeraj, et al.
Publicado: (2013) -
Intravitreal aflibercept treatment for choroidal neovascularization secondary to laser pointer
por: Keles, Ali, et al.
Publicado: (2020)